Gerri Henwood has served as our President, Chief Executive Officer and a director of the Company since November of 2019. From 2008 to December 2020, Ms. Henwood was the President, Chief Executive Officer and a director of Recro Pharma, Inc. (REPH), a company she founded in 2008. From 2006 to 2013, Ms. Henwood served as the President of Malvern Consulting Group, Inc., or MCG, a pharmaceutical incubator and consulting firm. Before founding MCG, Ms. Henwood was the President and Chief Executive Officer of Auxilium Pharmaceuticals, Inc. (formerly AUXL), or Auxilium, a biopharmaceutical company she founded in late 1999. From 1985 to 1999, Ms. Henwood was the founder and Chief Executive Officer of IBAH, Inc., or IBAH, a contract research organization listed on NASDAQ. Ms. Henwood began her career with Smith Kline & French, now part of GlaxoSmithKline plc. She rose through the ranks to be a brand manager, then the head of Regulatory and Medical Affairs for the U.S. business and then to the position of Group Director—Marketing in the International Pharmaceutical Division.

Ms. Henwood previously served on the board of directors of Tetraphase Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, from 2015 until its acquisition by La Jolla Pharmaceutical Company in June 2020. Before that, she served on the board of directors of Alkermes, Inc. and its successor company, Alkermes, plc, a global biopharmaceutical company, from 2003 until March 2015, and on the board of directors of MAP Pharmaceuticals, Inc., a biopharmaceuticals company, from 2004 until its acquisition by Allergan, Inc. in March 2013. Ms. Henwood also served on the compensation committee of the board of directors of Tetraphase Pharmaceuticals, Inc.

Ms. Henwood holds a B.S. in Biology from Neumann University.

Jillian Dilmore has served as our Corporate Controller since January 2021 and our Director of Accounting from November 2019 until January 2021. Previously, Ms. Dilmore served as Director of Accounting from January 2019 through November 2019 and Senior Manager of Financial Reporting from September 2017 until January 2019 for Recro Pharma, Inc. Prior to that time, Ms. Dilmore served in a variety of roles for Royal DSM (formerly Kensey Nash Corporation), including Assistant Controller and Accounting Manager, from April 2011 until September 2017. Ms. Dilmore also worked as a Senior Auditor for Deloitte and Touche from September 2008 until April 2011.  Ms. Dilmore holds a B.A. in Accounting and Business Finance from Muhlenberg College. Ms. Dilmore is a Certified Public Accountant in Pennsylvania, a Chartered Global Management Accountant and is a member of the American Institute of Certified Public Accountants and the Pennsylvania Institute of Certified Public Accountants.

Diane Myers serves as the Senior Vice President, Regulatory and Quality. Before her role at Baudax Bio, she served as the Senior Vice President, Regulatory and Quality at Recro Pharma from 2008 to November 2019. From 2008 to 2014, Ms. Myers also served as Senior Vice President of Regulatory Affairs and Quality Assurance for MCG, a pharmaceutical incubator and consulting firm. From 2000 to 2008, Ms. Myers served as Vice President of Regulatory Affairs and Quality at Auxilium. In addition, for more than 15 years she held positions of increasing responsibility at GlaxoSmithKline plc in the Quality Control and Quality Assurance groups within the Biopharmaceutical Research and Development Division.

Ms. Myers holds a B.S. in Biology from Neumann University.